Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Bloomfield

Showing results (261-270 of 289) with videos related to

Pageof 29
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemiaS M Tanner, J L Austin, G Leone, et al.
Cancer Research|October 5, 2001
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B studyS P Whitman, K J Archer, L Feng, et al.
Blood|September 15, 1996
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemiaJ Jurlander, M A Caligiuri, T Ruutu, et al.
Leukemia|March 25, 2017
No evidence for microsatellite instability in acute myeloid leukemiaC J Walker, A-K Eisfeld, L K Genutis, et al.
Blood|November 15, 1993
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583H Ozer, S L George, C A Schiffer, et al.
Annals of Hematology|May 6, 2004
G3139, a BCL-2 antisense oligo-nucleotide, in AMLG Marcucci, W Stock, G Dai, et al.
Blood|February 15, 1996
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemiaM R Baer, S H Bernstein, V L Brunetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461J C Byrd, R B Weiss, D C Arthur, et al.
Leukemia|October 10, 2015
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETOS Goyama, J Schibler, A Gasilina, et al.
Leukemia|July 4, 2015
Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemiaR Sood, N F Hansen, F X Donovan, et al.
Pageof 29

Showing results (261-270 of 289) with videos related to

Sort By:
Pageof 29
Proceedings of the National Academy of Sciences of the United States of America|November 15, 2001
BAALC, the human member of a novel mammalian neuroectoderm gene lineage, is implicated in hematopoiesis and acute leukemiaS M Tanner, J L Austin, G Leone, et al.
Cancer Research|October 5, 2001
Absence of the wild-type allele predicts poor prognosis in adult de novo acute myeloid leukemia with normal cytogenetics and the internal tandem duplication of FLT3: a cancer and leukemia group B studyS P Whitman, K J Archer, L Feng, et al.
Blood|September 15, 1996
Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemiaJ Jurlander, M A Caligiuri, T Ruutu, et al.
Leukemia|March 25, 2017
No evidence for microsatellite instability in acute myeloid leukemiaC J Walker, A-K Eisfeld, L K Genutis, et al.
Blood|November 15, 1993
Prolonged subcutaneous administration of recombinant alpha 2b interferon in patients with previously untreated Philadelphia chromosome-positive chronic-phase chronic myelogenous leukemia: effect on remission duration and survival: Cancer and Leukemia Group B study 8583H Ozer, S L George, C A Schiffer, et al.
Annals of Hematology|May 6, 2004
G3139, a BCL-2 antisense oligo-nucleotide, in AMLG Marcucci, W Stock, G Dai, et al.
Blood|February 15, 1996
Biological effects of recombinant human granulocyte colony-stimulating factor in patients with untreated acute myeloid leukemiaM R Baer, S H Bernstein, V L Brunetto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461J C Byrd, R B Weiss, D C Arthur, et al.
Leukemia|October 10, 2015
UBASH3B/Sts-1-CBL axis regulates myeloid proliferation in human preleukemia induced by AML1-ETOS Goyama, J Schibler, A Gasilina, et al.
Leukemia|July 4, 2015
Somatic mutational landscape of AML with inv(16) or t(8;21) identifies patterns of clonal evolution in relapse leukemiaR Sood, N F Hansen, F X Donovan, et al.
Pageof 29